RxDoctor Payments Data

Eric Shulman, MD

Clinical Cardiac Electrophysiology · Downers Grove, ILNPI 1598008559

Payments from drug & device makers

$17,801in general payments, 2019–2025

Across 315 payments — averaging $56.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$7K
  • Medtronic$2K
  • Medical Device Business Services, Inc.$2K
  • Boston Scientific$2K
  • Biotronik Inc.$1K
  • Biosense Webster, Inc.$1K
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$1341%
  • Travel & lodging$5,52831%
  • Food & beverage$12,14068%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,801 in reported general payments places this provider in the 30th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$211,273
Medicare patients
757
Services billed
2,508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban940$810,857
MultaqDronedarone Hcl121$130,069
XareltoRivaroxaban151$128,412
Dofetilide52$12,491
Dabigatran EtexilateDabigatran Etexilate Mesylate42$9,969
Mexiletine Hcl62$5,741
Amiodarone Hcl365$4,051
Metoprolol Succinate317$3,413
SotalolSotalol Hcl101$2,564
Diltiazem 24hr Er (Cd)Diltiazem Hcl63$2,424
Metoprolol Tartrate251$1,173
ClopidogrelClopidogrel Bisulfate57$733
Sucralfate35$695
Dilt-XrDiltiazem Hcl23$640
Verapamil ErVerapamil Hcl11$406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$280$810,857940 claims
Sanofi-aventis U.S. LLCMultaq$135$130,069121 claims
Johnson & JohnsonXarelto$669$128,412151 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

Other clinical cardiac electrophysiology in Downers Grove

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →